MITAPIVAT

1331 reported adverse events

Drug classes: Pyruvate Kinase Activator [EPC]

These side effects are most commonly reported by patients taking MITAPIVAT:

# Side effect Count
0 HAEMOGLOBIN DECREASED 230
1 PRODUCT DOSE OMISSION ISSUE 197
2 HEADACHE 173
3 FATIGUE 159
4 INSOMNIA 124
5 OFF LABEL USE 123
6 NAUSEA 86
7 ARTHRALGIA 82
8 DRUG INEFFECTIVE 76
9 BACK PAIN 64
See all common reactions for MITAPIVAT

MITAPIVAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIVER IRON CONCENTRATION DECREASED 1 0.5000
1 FREE FATTY ACIDS DECREASED 1 0.2500
2 RETICULOCYTE HAEMOGLOBIN DECREASED 1 0.1429
3 PYRUVATE KINASE DEFICIENCY ANAEMIA 1 0.1111
4 TESTICULAR RUPTURE 1 0.0833
5 CONCOMITANT DRUG EFFECT DECREASED 3 0.0698
6 HEPATITIS C RNA DECREASED 1 0.0667
7 HAPTOGLOBIN ABNORMAL 4 0.0435
8 INCREASED NEED FOR SLEEP 9 0.0386
9 SERUM FERRITIN ABNORMAL 8 0.0250
See all enriched reactions for MITAPIVAT